Skip to main content Skip to main navigation menu Skip to site footer

The effectiveness of multiflora honey to prevent hepatotoxicity in invasive ductal breast cancer patients with FAC chemotherapy

Abstract

Background: Breast cancer is an epithelial malignancy of the breast duct, which chemotherapy is one of the treatment modalities. Hepatotoxicity is known as one of the side effects of chemotherapy. Multiflora honey provides hepatoprotective effects through its phenolic acid and flavonoid compounds. This study will evaluate the effect of Honey in preventing hepatotoxicity in ductal invasive breast cancer patients receiving FAC chemotherapy.

Methods: An experimental study with double-blind, randomized pre and post-test with control group design. About 36 ductal invasive breast cancer patients were divided into 2 groups, the control group who received FAC chemotherapy and the treatment group who received chemotherapy and 90 ml/day honey consumption for 14 days. The patient's Aspartate Transaminase (AST), Alanine Transaminase (ALT), Alkaline Phosphatase (ALP), and Gamma-Glutamyl Transferase (GGT) enzyme levels before and after 14 days of the study were assessed. Data were analyzed using SPSS version 15 for Windows by Mann-Whitney test and Wilcoxon tests.

Results: There was a significant difference in AST (33.72±44.35 U/L vs. 23.22±4.48 U/L; p<0.001) and ALT (29.72±16.96 U/L vs. 26.06±9.19 U/L; p=0.020) levels in the treatment vs. control group. In addition, a significant difference of ALP (107.00±65.89 U/L vs. 103.17±35.30 U/L; p=0.009) and GGT (56.61±58.16 U/L vs. 51.33±27.50 U/L; p=0.035) levels in the treatment vs. control group was also found in this study.

Conclusion: Multiflora honey has a hepatoprotective effect for invasive ductal breast cancer patients receiving FAC chemotherapy.

References

  1. Richie RC, Swanson JO. Breast cancer: a review of the literature. J Insur Med. 2003;35(2):85-101.
  2. Martin MY, Evans MB, Kratt P, Pollack LA, Smith JL, Oster R, et al. Meeting the information needs of lower income cancer survivors: Results of a randomized control trial evaluating the American cancer society's "i can cope." J Health Commun. 2014;19(4):441–59.
  3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
  4. Anwar SL, Raharjo CA, Herviastuti R, Dwianingsih EK, Setyoheriyanto D, Avanti WS, et al. Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study. BMC Womens Health. 2019;19(1):28.
  5. Kementerian Kesehatan Republik Indonesia (KEMENKES RI). Profil Kesehatan Tahun 2014. Jakarta. 2015;51(6):40.
  6. Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov. 2006;5(2):147-159.
  7. The EBCTCG Secretariat. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998;352(9132):930-942.
  8. Wiranata S, Anjani IAW, Saputra IPGS, Sadvika IGAS, Prabawa IPY, Supadmanaba IG, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to- Lymphocyte Ratio as a Stage Determination in Breast Cancer. Open Access Macedonian Journal of Medical Sciences. 2020;8(B):1058-1063.
  9. Pusat Data dan Informasi Kementerian Kesehatan RI. Situasi Penyakit Kanker. J Chem Inf Model. 2015;53(9):1689–99.
  10. Vaughan WP, Wilcox PM, Alderson PO, Ettinger DS, Abeloff MD. Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast. Med Pediatr Oncol. 1979;7(4):351-359.
  11. Larroquette CA, Hortobagyi GN, Buzdar AU, Holmes FA. Subclinical hepatic toxicity during combination chemotherapy for breast cancer. JAMA. 1986;256(21):2988-2990.
  12. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA. Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol. 1993;11(12):2386-2390.
  13. Liu Y, Li ZY, Li X, Wang JN, Huang QA, Huang Y. Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection. Breast. 2017;35:191-195.
  14. Cattley RC, Radinsky RR. Cancer therapeutics: understanding the mechanism of action. Toxicol Pathol. 2004;32 Suppl 1:116-121.
  15. Gao H, Li Q, Wei W, Jiang YI, Yang H, Liu J. Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials. Mol Clin Oncol. 2015;3(5):1145-1151.
  16. Porcza LM, Simms C, Chopra M. Honey and Cancer: Current Status and Future Directions. Diseases. 2016;4(4):30.
  17. Sanz ML, Polemis N, Morales V, Corzo N, Drakoularakou A, Gibson GR, et al. In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J Agric Food Chem. 2005;53(8):2914-21.
  18. Zakaria Z, Zainal Abidin ZF, Gan SH, Wan Abdul Hamid WZ, Mohamed M. Effects of honey supplementation on safety profiles among postmenopausal breast cancer patients. J Taibah Univ Med Sci. 2018;13(6):535-540.
  19. Karadeniz A, Simsek N, Karakus E, Yildirim S, Kara A, Can I, et al. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid Med Cell Longev. 2011;2011:981793.
  20. Al-Waili NS. Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals. J Med Food. 2003;6(2):135-140.
  21. Ahmed S, Othman NH. Honey as a potential natural anticancer agent: a review of its mechanisms. Evid Based Complement Alternat Med. 2013;2013:829070.
  22. Floyd J, Mirza I, Sachs B, Perry MC. Hepatotoxicity of chemotherapy. Semin Oncol. 2006;33(1):50-67.
  23. Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol. 2001;62(9):1175-1183.
  24. Araújo JR, Gonçalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res. 2011;31(2):77-87.
  25. Hussein SZ, Mohd Yusoff K, Makpol S, Mohd Yusof YA. Gelam Honey Inhibits the Production of Proinflammatory, Mediators NO, PGE(2), TNF-?, and IL-6 in Carrageenan-Induced Acute Paw Edema in Rats. Evid Based Complement Alternat Med. 2012;2012:109636.
  26. McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF, et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood. 2003;101(5):2043-8.

How to Cite

Sidabutar, D. F. M., Budijitno, S., & Prasetyo, A. (2021). The effectiveness of multiflora honey to prevent hepatotoxicity in invasive ductal breast cancer patients with FAC chemotherapy. Bali Medical Journal, 10(3), 982–987. https://doi.org/10.15562/bmj.v10i3.2660

HTML
0

Total
14

Share

Search Panel

Dwi Feris Martua Sidabutar
Google Scholar
Pubmed
BMJ Journal


Selamet Budijitno
Google Scholar
Pubmed
BMJ Journal


Awal Prasetyo
Google Scholar
Pubmed
BMJ Journal